Xeris Biopharma Holdings
(NASDAQ:XERS)
$1.71
0.01[0.59%]
At close: Apr 25
$1.71
0[0.00%]
After Hours: 6:54PM EDT

Xeris Biopharma Holdings Stock (NASDAQ:XERS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Date Announced
ticker
Company Name
Period
Period Year
Min EPS
Max EPS
Estimate
Min Rev
Max Rev
Revenue Estimate
Get Alert
03/06/2024XERS
Xeris Biopharma Holdings
FY2024$170.00M$200.00M$188.01MGet Alert
01/04/2024XERS
Xeris Biopharma Holdings
FY2023$165.00M$165.00M$161.96MGet Alert
11/09/2023XERS
Xeris Biopharma Holdings
FY2023$160.00M$165.00M$158.23MGet Alert
10/16/2023XERS
Xeris Biopharma Holdings
FY2023$155.00M$165.00M$158.23MGet Alert
08/08/2023XERS
Xeris Biopharma Holdings
FY2023$145.00M$165.00M$149.35MGet Alert
05/09/2023XERS
Xeris Biopharma Holdings
FY2023$135.00M$165.00M$146.90MGet Alert
03/08/2023XERS
Xeris Biopharma Holdings
FY2023$135.00M$165.00M$152.31MGet Alert

FAQ

Q

What is the most recent guidance for Xeris Biopharma Holdings (XERS)?

A

There have been no specific sales or earnings guidance reported for Xeris Biopharma Holdings in recent months.

Browse guidance and forecast on all stocks.

People Also Watch